USPTO trademark

CELFORPHARMA

RegisteredUSPTOWord and designClass 35Class 41Class 42

"CELFORPHARMA" is a word and design mark owned by CELforPharma B.V., filed at the USPTO on January 16, 2025. It is registered and covers classes 35, 41 and 42.

Get this data via the API
Official USPTO record
CELFORPHARMA trademark as filed
As filed with the USPTO
Status
Registered
Since December 2, 2025
Filed
January 16, 2025
Registered
December 2, 2025
Expires
Not recorded
Application no.
99004087
Registration no.
8046926
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
3 classes
Ownership

Who owns CELFORPHARMA

The owner and representative on file with the office.

Owner

CELforPharma B.V.

Machelen, Belgium

Representative

Michael C. Cerrati

Belzer PC

Goods and services

What the mark covers

The products and services CELFORPHARMA is filed for, grouped by Nice class.

  • Advertising services; Business management; Business administration; Providing office functions relating to the coordination of applications for courses, workshops, training and training courses for the pharmaceutical industry; Marketing services; Market canvassing in the nature of market research and market analysis services for the pharmaceutical industry; business economics consultancy, business organization consultancy, and business administration consultancy, all for the pharmaceutical industry; Office functions in the nature of maintaining, collecting, managing and updating data files for others in the pharmaceutical industry; Arranging special events for publicity or commercial purposes for the pharmaceutical industry; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networks, such as the Internet

  • Education services, namely, arranging and conducting of seminars, instruction courses, workshops, congresses, training seminars, lectures, and educational courses for managers in the pharmaceutical industry and in the fields of business development, market forecasting, market penetration, risk analysis, strategy and brand development; Providing of training in the pharmaceutical industry and in the fields of business development, market forecasting, market penetration, risk analysis, strategy and brand development; Educational and entertainment services, namely, providing continuing programs in the pharmaceutical industry and in the fields of business development, market forecasting, market penetration, risk analysis, strategy and brand development accessible live and via audio, video and web-based applications; Publishing and lending of books, journals, newspapers, magazines, articles, press releases, leaflets, brochures, information bulletins and other printed matter and periodicals, and audiovisual and multimedia products in the field of pharmaceuticals for the pharmaceutical industry; Providing non-downloadable electronic publications in the nature of books, journals, newspapers, magazines, articles, press releases, leaflets, brochures, information bulletins and other printed matter and periodicals in the field of pharmaceuticals for the pharmaceutical industry from a global computer network or the Internet; Publication of electronic books and journals online; Publication of texts, other than publicity texts; Translation and language interpretation; Educational services in the fields of science and technology, namely, education research and developing teaching materials for courses, workshops, training and training courses for the pharmaceutical industry; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networks, such as the Internet

  • Scientific and technological services, namely, research and new product design for the pharmaceutical industry in the field of pharmaceuticals; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networks, such as the Internet

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Examiner's amendment entered
  8. Notification of examiners amendment e-mailed
  9. Examiners amendment e-mailed
  10. Examiners amendment -written

10 earlier steps on the official record.

FAQ

About CELFORPHARMA

Who owns the trademark "CELFORPHARMA"?

The USPTO trademark "CELFORPHARMA" (application 99004087) is owned by CELforPharma B.V.

What is the status of "CELFORPHARMA"?

Its status at the USPTO is: registered.

When was "CELFORPHARMA" registered?

It was registered on December 2, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CELFORPHARMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a5d-b85b-7749-99f1-4c019c14ceb8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a5d-b85b-7749-99f1-4c019c14ceb8",
  "object": "trademark",
  "mark_text": "CELFORPHARMA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99004087",
  "filing_date": "2025-01-16",
  "nice_classes": [
    35,
    41,
    42
  ],
  "owners": [
    {
      "name": "CELforPharma B.V.",
      "entity_id": null
    }
  ]
}